Suven Pharmaceuticals Limited

NSEI:SUVENPHAR Rapporto sulle azioni

Cap. di mercato: ₹329.7b

Suven Pharmaceuticals Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Sudhir Singh

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO1.2yrs
Proprietà del CEOn/a
Durata media del managementless than a year
Durata media del Consiglio di amministrazione1.1yrs

Aggiornamenti recenti sulla gestione

Recent updates

These 4 Measures Indicate That Suven Pharmaceuticals (NSE:SUVENPHAR) Is Using Debt Safely

Dec 15
These 4 Measures Indicate That Suven Pharmaceuticals (NSE:SUVENPHAR) Is Using Debt Safely

Robust Earnings May Not Tell The Whole Story For Suven Pharmaceuticals (NSE:SUVENPHAR)

Aug 03
Robust Earnings May Not Tell The Whole Story For Suven Pharmaceuticals (NSE:SUVENPHAR)

Does Suven Pharmaceuticals (NSE:SUVENPHAR) Have A Healthy Balance Sheet?

May 12
Does Suven Pharmaceuticals (NSE:SUVENPHAR) Have A Healthy Balance Sheet?

Suven Pharmaceuticals Limited (NSE:SUVENPHAR) Investors Are Less Pessimistic Than Expected

Mar 26
Suven Pharmaceuticals Limited (NSE:SUVENPHAR) Investors Are Less Pessimistic Than Expected

Here's Why We Think Suven Pharmaceuticals (NSE:SUVENPHAR) Is Well Worth Watching

Mar 07
Here's Why We Think Suven Pharmaceuticals (NSE:SUVENPHAR) Is Well Worth Watching

These 4 Measures Indicate That Suven Pharmaceuticals (NSE:SUVENPHAR) Is Using Debt Safely

Nov 30
These 4 Measures Indicate That Suven Pharmaceuticals (NSE:SUVENPHAR) Is Using Debt Safely

Do Suven Pharmaceuticals's (NSE:SUVENPHAR) Earnings Warrant Your Attention?

Sep 03
Do Suven Pharmaceuticals's (NSE:SUVENPHAR) Earnings Warrant Your Attention?

Here's Why Suven Pharmaceuticals (NSE:SUVENPHAR) Can Manage Its Debt Responsibly

Aug 04
Here's Why Suven Pharmaceuticals (NSE:SUVENPHAR) Can Manage Its Debt Responsibly

Analysts Have Made A Financial Statement On Suven Pharmaceuticals Limited's (NSE:SUVENPHAR) Full-Year Report

Jun 11
Analysts Have Made A Financial Statement On Suven Pharmaceuticals Limited's (NSE:SUVENPHAR) Full-Year Report

With EPS Growth And More, Suven Pharmaceuticals (NSE:SUVENPHAR) Is Interesting

Apr 13
With EPS Growth And More, Suven Pharmaceuticals (NSE:SUVENPHAR) Is Interesting

Does Suven Pharmaceuticals (NSE:SUVENPHAR) Have A Healthy Balance Sheet?

Mar 08
Does Suven Pharmaceuticals (NSE:SUVENPHAR) Have A Healthy Balance Sheet?

Can Suven Pharmaceuticals Limited's (NSE:SUVENPHAR) ROE Continue To Surpass The Industry Average?

Feb 08
Can Suven Pharmaceuticals Limited's (NSE:SUVENPHAR) ROE Continue To Surpass The Industry Average?

AMMINISTRATORE DELEGATO

Sudhir Singh (59 yo)

1.2yrs

Mandato

Dr. Sudhir Kumar Singh, Ph.D. serves as Chief Executive Officer since September 29, 2023 at Suven Pharmaceuticals Ltd. He served as Chief Operating Officer of Aragen Life Sciences Private Limited from Sept...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Vivek Sharma
Executive Chairmanless than a yearNessun datoNessun dato
Sudhir Singh
Chief Executive Officer1.2yrsNessun datoNessun dato
Himanshu Agarwal
Chief Financial Officerless than a yearNessun datoNessun dato
Cyndrella Carvalho
Head of Investor Relationsno dataNessun datoNessun dato
Kundan Jha
Company Secretary & Compliance Officerless than a yearNessun datoNessun dato
Gaurav Bahadur
Chief Human Resources Officer1.2yrsNessun datoNessun dato
Vetukuri Venkata Naga Kali Vara Raju
MD & Directorno dataNessun datoNessun dato
Subba Komaravolu
Chief Strategy Officer1.2yrsNessun datoNessun dato
Declan Ryan
Chief Commercial Officerless than a yearNessun datoNessun dato
Sunder Venkatraman
Vice President of Corporate Affairs3.8yrsNessun datoNessun dato

1.0yrs

Durata media

54yo

Età media

Gestione esperta: Il team dirigenziale di SUVENPHAR non è considerato esperto (durata media 1 anni), il che suggerisce un nuovo team.


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Vivek Sharma
Executive Chairmanless than a yearNessun datoNessun dato
Vetukuri Venkata Naga Kali Vara Raju
MD & Director1.2yrsNessun datoNessun dato
Abhijit Mukherjee
Member of Advisory Council1.1yrsNessun datoNessun dato
Venkateswarlu Jasti
Member of Advisory Councilless than a year₹68.35mNessun dato
Shweta Jalan
Non-Executive Directorless than a yearNessun datoNessun dato
Pankaj Patwari
Non-Executive Director1.2yrsNessun datoNessun dato
Vinod Rao
Independent Director1.2yrs₹1.36mNessun dato
Matangi Gowrishankar
Independent Director1.2yrs₹1.36mNessun dato
Stefan Stoffel
Member of Advisory Council1.1yrsNessun datoNessun dato
Pravin Udhyavara Rao
Independent Directorless than a year₹1.07mNessun dato
Vaidheesh Annaswamy
Vice-Chairperson of Advisory Councilless than a year₹27.27mNessun dato
Kumarapuram Ananthakrishnan
Independent Director1.2yrs₹1.36m0.000050%
₹ 164.8k

1.1yrs

Durata media

62yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di SUVENPHAR non è considerato esperto (durata media del mandato 1.1 anni), il che suggerisce un nuovo consiglio.